BMGL

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Today, 9:30 AMNo clear catalyst identified for BMGL's 21% premarket plunge

Peers: AMS CCM CCEL NIVF BTMD DCGO PIII PARK JYNT WW

Scroll to Statements

Index	-
Market Cap	10.24M
Enterprise Value	17.07M
Income	-7.59M
Sales	11.16M
Book/sh	3.12
Cash/sh	0.66
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	70
IPO	Feb 26, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	0.92
P/B	2.10
P/C	9.85
P/FCF	-
EV/EBITDA	-
EV/Sales	1.53
Quick Ratio	1.84
Current Ratio	1.88
Debt/Eq	1.57
LT Debt/Eq	0.96
Option/Short	No / Yes

EPS (ttm)	-4.85
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	2.92% -
EPS Y/Y TTM	-1992.89%
Sales Y/Y TTM	49.15%
EPS Q/Q	187.19%
Sales Q/Q	68.79%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	67.97%
Insider Trans	0.00%
Inst Own	0.29%
Inst Trans	-
ROA	-57.05%
ROE	-148.66%
ROIC	-79.19%
Gross Margin	-2.33%
Oper. Margin	-31.64%
Profit Margin	-68.00%
SMA20	-6.17%
SMA50	-10.81%
SMA200	-35.09%
Trades

Shs Outstand	1.57M
Shs Float	0.50M
Short Float	2.53%
Short Ratio	0.21
Short Interest	0.01M
52W High	36.60 -82.12%
52W Low	4.60 42.41%
Volatility	21.58% 17.77%
ATR (14)	1.32
RSI (14)	47.19
Beta	0.07
Rel Volume	2.98
Avg Volume	60.33K
Volume	33,899

Perf Week	5.23%
Perf Month	-7.54%
Perf Quarter	-7.56%
Perf Half Y	-15.66%
Perf YTD	11.31%
Perf Year	-78.69%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	8.12
Price	6.55
Change	-19.40%

Jul-10-26 06:30AM	BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Jun-10-26 01:58PM	Why Did BMGL Stock Slump 18% Today? (Stocktwits) -8.01%
07:00AM	BMGL to Effect Reverse Share Split on June 22, 2026 (GlobeNewswire)
Mar-24-26 06:30AM	Compliance With Nasdaq Periodic Filing Requirement (GlobeNewswire) -7.26%
Jan-23-26 04:30PM	Receipt of Delinquency Notification from Nasdaq (GlobeNewswire)
04:30PM	Loading…
Dec-01-25 04:30PM	Receipt of Delinquency Notification from Nasdaq (GlobeNewswire)
Jul-17-25 04:30PM	Basel Medical Group Putting On Hold On The Acquisition of BTC Digital Asset (GlobeNewswire) -14.29%
Jun-26-25 04:15PM	Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising (GlobeNewswire) -12.62%
May-29-25 10:11AM	Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility (GlobeNewswire)
May-22-25 09:20AM	Basel Medical Group Ltd Enters into US$ 1.0 Billion Bitcoin (BTC) Purchase Agreement (GlobeNewswire) -36.90%
May-20-25 09:20AM	Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities (GlobeNewswire) -6.57%
May-16-25 09:20AM	Basel Medical Group Ltd Kicks Off US$ 1.0 Billion Bitcoin (BTC) Acquisition Strategy Move (GlobeNewswire) -9.89%
Apr-30-25 12:15AM	Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia (GlobeNewswire)
Apr-11-25 02:30AM	Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia (GlobeNewswire)
Mar-19-25 04:10PM	Basel Medical Group Ltd Announces Exercise of Overallotment Option (GlobeNewswire)
04:00AM	Loading…
Mar-03-25 04:00AM	Basel Medical Group Ltd Announces Closing of US$8,820,000 Initial Public Offering (GlobeNewswire)
Feb-25-25 05:08PM	Basel Medical Group Ltd Prices US$8,820,000 Initial Public Offering (GlobeNewswire)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Executive Chairman of the BoardMr. Keng Leong Fung

Chief Executive OfficerDr. Yen Feng Chhoa M.D.

Interim Chief Financial OfficerMr. Chun How Neo

Chief Commercial Officer & DirectorMr. Boon Chye Tan

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Basel Medical Group Ltd

Upgrade your Finviz experience